Italy Apheresis Equipment Market Size & Outlook, 2023-2030
Italy apheresis equipment market, 2018-2030 (US$M)
Related Markets
Italy apheresis equipment market highlights
- The Italy apheresis equipment market generated a revenue of USD 112.9 million in 2023 and is expected to reach USD 212.9 million by 2030.
- The Italy market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
- In terms of segment, disposable apheresis kits was the largest revenue generating product in 2023.
- Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Apheresis equipment market data book summary
| Market revenue in 2023 | USD 112.9 million |
| Market revenue in 2030 | USD 212.9 million |
| Growth rate | 9.5% (CAGR from 2023 to 2030) |
| Largest segment | Disposable apheresis kits |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Disposable Apheresis Kits, Devices |
| Key market players worldwide | Asahi Kasei Corp, Terumo Corp, Fresenius SE & Co KGaA, Haemonetics Corp, B. Braun, Nikkiso Co Ltd, Mallinckrodt PLC Ordinary Shares - New |
Other key industry trends
- In terms of revenue, Italy accounted for 3.9% of the global apheresis equipment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany apheresis equipment market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 343.3 million by 2030.
Disposable apheresis kits was the largest segment with a revenue share of 72.28% in 2023. Horizon Databook has segmented the Italy apheresis equipment market based on disposable apheresis kits, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of well-developed healthcare services in Italy is one of the major factors driving the market. Moreover, the increasing prevalence of blood-related disorders is anticipated to drive market growth for apheresis equipment. In September 2022, Tr1X, led by Professor Maria Grazia Roncarolo, pioneered advanced therapies for autoimmune and inflammatory diseases, leveraging genetic engineering to produce regulatory T cells.
Backed by Neva Sgr's investment, they aim to revolutionize medicine by developing a single treatment targeting immune system balance, advancing toward FDA clinical trials in 2023. Advancements in treatments for autoimmune and inflammatory diseases, such as those pursued by Tr1X through genetic engineering, can impact the growth of the apheresis equipment market.
As more effective therapies are developed, there may be an increased demand for apheresis procedures to support treatment protocols, particularly for conditions where apheresis is a therapeutic option. This synergy between innovative treatments and supporting medical equipment can contribute to the market's expansion & relevance in healthcare.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Apheresis Equipment Market Scope
Apheresis Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy apheresis equipment market size, by product, 2018-2030 (US$M)
Italy Apheresis Equipment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
